Empegfilgrastim Uses, Dosage, Side Effects and more
Empegfilgrastim is under investigation in clinical trial NCT01569087 (Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Empegfilgrastim |
| Generic | Empegfilgrastim |
| Empegfilgrastim Other Names | Colony-stimulating factor, granulocyte (synthetic human), 30-kilodalton pegylated, Empegfilgrastim |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
